Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older

作者
Yuko Komase,Akimoto Asako,Akihiro Kobayashi,Sharma R
出处
期刊:Taylor and Francis Group - Dove Medical Press
摘要

Yuko Komase,1 Akimoto Asako,2 Akihiro Kobayashi,3 Raj Sharma4 1Department of Respiratory Internal Medicine, St Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Kanagawa, Japan; 2MA Respiratory Department, Development and Medical Affairs Unit, GlaxoSmithKline KK, Tokyo, Japan; 3Biomedical Data Sciences Department, GlaxoSmithKline KK, Tokyo, Japan; 4Global Respiratory Franchise Medical Department, GSK, Stockley Park, UK Background: In patients receiving inhaled medication, dissatisfaction with and difficulty in using the inhaler can affect treatment adherence. The incidence of handling errors is typically higher in the elderly than in younger people. The aim of the study was to assess inhaler preference for and handling errors with the ELLIPTA® dry powder inhaler (DPI), (GSK), compared with the established BREEZHALER™, a single-dose capsule DPI (Novartis), in inhalation device-naïve Japanese volunteers aged ≥40 years. Methods: In this open-label, nondrug interventional, crossover DPI preference study comparing the ELLIPTA DPI and BREEZHALER, 150 subjects were randomized to handle the ELLIPTA or BREEZHALER DPIs until the point of inhalation, without receiving verbal or demonstrative instruction (first attempt). Subjects then crossed over to the other inhaler. Preference was assessed using a self-completed questionnaire. Inhaler handling was assessed by a trained assessor using a checklist. Subjects did not inhale any medication in the study, so efficacy and safety were not measured. Results: The ELLIPTA DPI was preferred to the BREEZHALER by 89% of subjects (odds ratio [OR] 70.14, 95% confidence interval [CI] 33.69–146.01; P-value not applicable for this inhaler) for ease of use, by 63% of subjects (OR 2.98, CI 1.87–4.77; P<0.0001) for ease of determining the number of doses remaining in the inhaler, by 91% for number of steps required, and by 93% for time needed for handling the inhaler. The BREEZHALER was preferred to the ELLIPTA DPI for comfort of the mouthpiece by 64% of subjects (OR 3.16, CI 1.97–5.06; P<0.0001). The incidence of handling errors (first attempt) was 11% with ELLIPTA and 68% with BREEZHALER; differences in incidence were generally similar when analyzed by age (< or ≥65 years) or sex. Conclusion: These data, obtained in an inhalation device-naïve population, suggest that the ELLIPTA DPI is preferred to an established alternative based on its ease-of-use features and is associated with fewer handling errors. Keywords: chronic obstructive pulmonary disease, dry powder inhaler, ELLIPTA®, BREEZHALER™

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
机智亦云完成签到,获得积分10
刚刚
LYN完成签到,获得积分10
刚刚
今天也不想搬砖完成签到,获得积分10
刚刚
感谢饺子123转发科研通微信,获得积分50
刚刚
zz完成签到 ,获得积分10
刚刚
信仰完成签到,获得积分10
刚刚
奋斗平卉完成签到,获得积分10
1秒前
康敏艳完成签到,获得积分10
1秒前
小梦完成签到,获得积分10
1秒前
爱我不上火完成签到 ,获得积分10
2秒前
科目三的应助被化工兔采纳,获得10
2秒前
怕孤单的新波完成签到,获得积分20
2秒前
感谢醉卧星河转发科研通微信,获得积分50
2秒前
cch完成签到,获得积分10
3秒前
蔡能涛完成签到 ,获得积分10
3秒前
Orange的应助被liqunzhang采纳,获得10
3秒前
cc完成签到 ,获得积分10
3秒前
子非我完成签到,获得积分10
3秒前
衣裳薄完成签到,获得积分10
3秒前
执名之念完成签到,获得积分10
4秒前
臣四水儿完成签到 ,获得积分10
4秒前
英俊的铭的应助被Cx330采纳,获得10
4秒前
感谢sisisi转发科研通微信,获得积分50
5秒前
自由甜瓜完成签到,获得积分10
5秒前
任性的傲柏完成签到,获得积分0
5秒前
Eli发布了新的文献求助10
5秒前
00gi完成签到,获得积分10
5秒前
小冯1完成签到,获得积分10
6秒前
郑瑞完成签到 ,获得积分10
6秒前
清新的石头完成签到,获得积分10
6秒前
好好完成签到,获得积分10
6秒前
yygz0703完成签到 ,获得积分10
6秒前
梨恩完成签到,获得积分20
6秒前
丁丁当当完成签到,获得积分10
6秒前
hitech完成签到,获得积分10
7秒前
感谢selena转发科研通微信,获得积分50
7秒前
777完成签到 ,获得积分10
7秒前
阿拉丁发布了新的文献求助20
7秒前
谦让的鹏煊完成签到,获得积分10
8秒前
风随完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173463
求助须知:如何正确求助?哪些是违规求助? 9565690
关于积分的说明 21781315
捐赠科研通 7767647
什么是DOI,文献DOI怎么找? 3431597
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476808